However, there was a significant aggregation of PLP variants in the BRC repeats (P = 0.019) and DNA binding domain (P = 0.015) of BRCA2 in cancer patients, whereas in healthy individuals, PLP variants were scattered across functional domains (Fig. 3). Here, BRCA2 is linked to cancer.